Developmental aspects of cardiac arrhythmogenesis

Cardiovascular Research

Volumn 91, Issue 2, 2011, Pages 243-251

  Postma, Alex V ^a   Christoffels, Vincent M ^a   Bezzina, Connie R ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

Cardiac development; Genetic variation; Ion channels; Transcription factors

Indexed keywords

ARRHYTHMOGENESIS; EPIGENETICS; GAP JUNCTION; GENE CONTROL; GENE EXPRESSION; GENETIC ASSOCIATION; GENETIC VARIABILITY; HEART ARRHYTHMIA; HEART DEVELOPMENT; HEART ELECTROPHYSIOLOGY; HEART FUNCTION; HUMAN; NONHUMAN; PRIORITY JOURNAL; REVIEW;

ANIMALS; ARRHYTHMIAS, CARDIAC; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GENETIC PREDISPOSITION TO DISEASE; HEART CONDUCTION SYSTEM; HOMEODOMAIN PROTEINS; HUMANS; ION CHANNELS; PHENOTYPE; T-BOX DOMAIN PROTEINS; TRANSCRIPTION FACTORS;

EID: 79959922939     PISSN: 00086363     EISSN: 17553245     Source Type: Journal    
DOI: 10.1093/cvr/cvr134     Document Type: Review

References (100)

1. Boukens BJ, Christoffels VM, Coronel R, Moorman AF. Developmental basis for electrophysiological heterogeneity in the ventricular and outflow tract myocardium as a substrate for life-threatening ventricular arrhythmias. Circ Res 2009;104: 19-31.
2. Bruneau BG. Transcriptional regulation of vertebrate cardiac morphogenesis. Circ Res 2002;90:509-519. (Pubitemid 34640900)
3. Habets PE, Moorman AF, Christoffels VM. Regulatory modules in the developing heart. Cardiovasc Res 2003;58:246-263. (Pubitemid 36570385)
4. Moorman AF, Christoffels VM. Cardiac chamber formation: development, genes, and evolution. Physiol Rev 2003;83:1223-1267. (Pubitemid 37222272)
5. Christoffels VM, Smits GJ, Kispert A, Moorman AF. Development of the pacemaker tissues of the heart. Circ Res 2010;106:240-254.
6. Basson CT, Bachinsky DR, Lin RC, Levi T, Elkins JA, Soults J et al. Mutations in human TBX5 [corrected] cause limb and cardiac malformation in Holt-Oram syndrome. Nat Genet 1997;15:30-35.
7. Schott JJ, Benson DW, Basson CT, Pease W, Silberbach GM, Moak JP et al. Congenital heart disease caused by mutations in the transcription factor NKX2-5. Science 1998;281:108-111. (Pubitemid 28354055)
8. Costantini DL, Arruda EP, Agarwal P, Kim KH, Zhu Y, Zhu W et al. The homeodo-main transcription factor Irx5 establishes the mouse cardiac ventricular repolariza-tion gradient. Cell 2005;123:347-358. (Pubitemid 41457222)
9. Hoogaars WM, Engel A, Brons JF, Verkerk AO, de Lange FJ, Wong LY et al. Tbx3 controls the sinoatrial node gene program and imposes pacemaker function on the atria. Genes Dev 2007;21:1098-1112. (Pubitemid 46686478)
10. Aanhaanen WT, Boukens BJ, Sizarov A, Wakker V, de Gier-de Vries C, van Ginneken AC et al. Defective Tbx2-dependent patterning of the atrioventricular canal myocardium causes accessory pathway formation in mice. J Clin Invest 2011; 121:534-544.
11. Gudbjartsson DF, Arnar DO, Helgadottir A, Gretarsdottir S, Holm H, Sigurdsson A et al. Variants conferring risk of atrial fibrillation on chromosome 4q25. Nature 2007; 448:353-357. (Pubitemid 47080348)
12. Kaab S, Darbar D, van Noord C, Dupuis J, Pfeufer A, Newton-Cheh C et al. Large scale replication and meta-analysis of variants on chromosome 4q25 associated with atrial fibrillation. Eur Heart J 2009;30:813-819.
13. Pfeufer A, van Noord C, Marciante KD, Arking DE, Larson MG, Smith AV et al. Genome-wide association study of PR interval. Nat Genet 2010;42:153-159.
14. Sotoodehnia N, Isaacs A, de Bakker PI, Dorr M, Newton-Cheh C, Nolte IM et al. Common variants in 22 loci are associated with QRS duration and cardiac ventricular conduction. Nat Genet 2010;42:1068-1076.
15. Holm H, Gudbjartsson DF, Arnar DO, Thorleifsson G, Thorgeirsson G, Stefansdottir H et al. Several common variants modulate heart rate, PR interval and QRS duration. Nat Genet 2010;42:117-122.
16. Buckingham M, Meilhac S, Zaffran S. Building the mammalian heart from two sources of myocardial cells. Nat Rev Genet 2005;6:826-835.
17. van den Berg G, Abu-Issa R, de Boer BA, Hutson MR, de Boer PA, Soufan AT et al. A caudal proliferating growth center contributes to both poles of the forming heart tube. Circ Res 2009;104:179-188.
18. Anderson RH, Christoffels VM, Moorman AF. Controversies concerning the anatomical definition of the conduction tissues. Anat Rec B New Anat 2004;280:8-14. (Pubitemid 39331779)
19. Christoffels VM, Moorman AFM. Development of the cardiac conduction system: why are some regions of the heart more arrhythmogenic than others?. Circ Arrhythm Electrophysiol 2009;2:195-207.
20. Alcolea S, Theveniau-Ruissy M, Jarry-Guichard T, Marics I, Tzouanacou E, Chauvin JP et al. Downregulation of connexin 45 gene products during mouse heart development. Circ Res 1999;84:1365-1379. (Pubitemid 29293214)
21. Van Mierop LH. Location of pacemaker in chick embryo heart at the time of initiation of heartbeat. Am J Physiol 1967;212:407-415.
22. Mommersteeg MT, Hoogaars WM, Prall OW, de Gier-de Vries C, Wiese C, Clout DE et al. Molecular pathway for the localized formation of the sinoatrial node. Circ Res 2007;100:354-362.
23. Wiese C, Grieskamp T, Airik R, Mommersteeg MT, Gardiwal A, de Gier-de Vries C et al. Formation of the sinus node head and differentiation of sinus node myocardium are independently regulated by Tbx18 and Tbx3. Circ Res 2009;104:388-397.
24. Horsthuis T, Buermans HP, Brons JF, Verkerk AO, Bakker ML, Wakker V et al. Gene expression profiling of the forming atrioventricular node using a novel tbx3-based node-specific transgenic reporter. Circ Res 2009;105:61-69.
25. Aanhaanen WT, Mommersteeg MT, Norden J, Wakker V, de Gier-de Vries C, Anderson RH et al. Developmental origin, growth, and three-dimensional architecture of the atrioventricular conduction axis of the mouse heart. Circ Res 2010;107: 728-736.
26. Habets PE, Moorman AF, Clout DE, van Roon MA, Lingbeek M, van Lohuizen M et al. Cooperative action of Tbx2 and Nkx2.5 inhibits ANF expression in the atrio-ventricular canal: implications for cardiac chamber formation. Genes Dev 2002;16: 1234-1246. (Pubitemid 34553104)
27. Moorman AF, Schumacher CA, de Boer PA, Hagoort J, Bezstarosti K, van den Hoff MJ et al. Presence of functional sarcoplasmic reticulum in the developing heart and its confinement to chamber myocardium. Dev Biol 2000;223:279-290. (Pubitemid 30485593)
28. Soufan AT, van den Berg G, Ruijter JM, de Boer PA, Van Den Hoff MJ, Moorman AF. A regionalized sequence of myocardial cell growth and proliferation characterizes early chamber formation. Circ Res 2006;99:545-552. (Pubitemid 44337827)
29. Lyons I, Parsons LM, Hartley L, Li R, Andrews JE, Robb L et al. Myogenic and mor-phogenetic defects in the heart tubes of murine embryos lacking the homeo box gene Nkx2-5. Genes Dev 1995;9:1654-1666.
30. Benson DW, Silberbach GM, Kavanaugh-McHugh A, Cottrill C, Zhang Y, Riggs S et al. Mutations in the cardiac transcription factor NKX2.5 affect diverse cardiac developmental pathways. J Clin Invest 1999;104:1567-1573. (Pubitemid 30002368)
31. Kasahara H, Wakimoto H, Liu M, Maguire CT, Converso KL, Shioi T et al. Progressive atrioventricular conduction defects and heart failure in mice expressing a mutant Csx/Nkx2.5 homeoprotein. J Clin Invest 2001;108:189-201. (Pubitemid 32656243)
32. Kasahara H, Benson DW. Biochemical analyses of eight NKX2.5 homeodomain mis-sense mutations causing atrioventricular block and cardiac anomalies. Cardiovasc Res 2004;64:40-51. (Pubitemid 39208921)
33. Meysen S, Marger L, Hewett KW, Jarry-Guichard T, Agarkova I, Chauvin JP et al. Nkx2.5 cell-autonomous gene function is required for the postnatal formation of the peripheral ventricular conduction system. Dev Biol 2007;303:740-753. (Pubitemid 46350762)
34. Moskowitz IP, Kim JB, Moore ML, Wolf CM, Peterson MA, Shendure J et al. A molecular pathway including Id2, Tbx5, and Nkx2-5 required for cardiac conduction system development. Cell 2007;129:1365-1376. (Pubitemid 46962088)
35. Gutierrez-Roelens I, De Roy L, Ovaert C, Sluysmans T, Devriendt K, Brunner HG et al. A novel CSX/NKX2-5 mutation causes autosomal-dominant AV block: are atrial fibrillation and syncopes part of the phenotype? Eur J Hum Genet 2006;14: 1313-1316. (Pubitemid 44804039)
36. Postma AV, Dekker LR, Soufan AT, Moorman AF. Developmental and genetic aspects of atrial fibrillation. Trends Cardiovasc Med 2009;19:123-130.
37. Masani F. Node-like cells in the myocardial layer of the pulmonary vein of rats: an ultrastructural study. J Anat 1986;145:133-142. (Pubitemid 16110889)
38. Perez-Lugones A, McMahon JT, Ratliff NB, Saliba WI, Schweikert RA, Marrouche NF et al. Evidence of specialized conduction cells in human pulmonary veins of patients with atrial fibrillation. J Cardiovasc Electrophysiol 2003;14:803-809. (Pubitemid 36994096)
39. Mommersteeg MT, Soufan AT, de Lange FJ, van den Hoff MJ, Anderson RH, Christoffels VM et al. Two distinct pools of mesenchyme contribute to the development of the atrial septum. Circ Res 2006;99:351-353. (Pubitemid 44253690)
40. Mommersteeg MT, Brown NA, Prall OW, de Gier-de Vries C, Harvey RP, Moorman AF et al. Pitx2c and Nkx2-5 are required for the formation and identity of the pulmonary myocardium. Circ Res 2007;101:902-909. (Pubitemid 350287177)
41. Christoffels VM, Mommersteeg MT, Trowe MO, Prall OW, de Gier-de Vries C, Soufan AT et al. Formation of the venous pole of the heart from an Nkx2-5-negative precursor population requires Tbx18. Circ Res 2006;98:1555-1563. (Pubitemid 44297079)
42. Cheng S, Keyes MJ, Larson MG, McCabe EL, Newton-Cheh C, Levy D et al. Long-term outcomes in individuals with prolonged PR interval or first-degree atrioventri-cular block. JAMA 2009;301:2571-2577.
43. Kispert A, Hermann BG. The Brachyury gene encodes a novel DNA binding protein. EMBO J 1993;12:4898-4899.
44. Bruneau BG, Logan M, Davis N, Levi T, Tabin CJ, Seidman JG et al. Chamber-specific cardiac expression of Tbx5 and heart defects in Holt-Oram syndrome. Dev Biol 1999;211:100-108. (Pubitemid 29315824)
45. Christoffels VM, Habets PE, Franco D, Campione M, de Jong F, Lamers WH et al. Chamber formation and morphogenesis in the developing mammalian heart. Dev Biol 2000;223:266-278. (Pubitemid 30485592)
46. Boogerd CJ, Dooijes D, Ilgun A, Mathijssen IB, Hordijk R, van de Laar IM et al. Functional analysis of novel TBX5 T-box mutations associated with Holt-Oram syndrome. Cardiovasc Res 2010;88:130-139.
47. Bruneau BG, Nemer G, Schmitt JP, Charron F, Robitaille L, Caron S et al. A murine model of Holt-Oram syndrome defines roles of the T-box transcription factor Tbx5 in cardiogenesis and disease. Cell 2001;106:709-721. (Pubitemid 32900662)
48. Hiroi Y, Kudoh S, Monzen K, Ikeda Y, Yazaki Y, Nagai R et al. Tbx5 associates with Nkx2-5 and synergistically promotes cardiomyocyte differentiation. Nat Genet 2001;28:276-280. (Pubitemid 32626032)
49. Fijnvandraat AC, Lekanne Deprez RH, Christoffels VM, Ruijter JM, Moorman AF. TBX5 overexpression stimulates differentiation of chamber myocardium in P19C16 embryonic carcinoma cells. J Muscle Res Cell Motil 2003;24:211-218. (Pubitemid 37323623)
50. Moskowitz IP, Pizard A, Patel VV, Bruneau BG, Kim JB, Kupershmidt S et al. The T-Box transcription factor Tbx5 is required for the patterning and maturation of the murine cardiac conduction system. Development 2004;131:4107-4116. (Pubitemid 39232168)
51. Basson CT, Cowley GS, Solomon SD, Weissman B, Poznanski AK, Traill TA et al. The clinical and genetic spectrum of the Holt-Oram syndrome (heart-hand syndrome). N Engl J Med 1994;330:885-891. (Pubitemid 24094967)
52. Postma AV, van de Meerakker JB, Mathijssen IB, Barnett P, Christoffels VM, Ilgun A et al. A gain-of-function TBX5 mutation is associated with atypical Holt-Oram syndrome and paroxysmal atrial fibrillation. Circ Res 2008;102:1433-1442.
53. Mori AD, Zhu Y, Vahora I, Nieman B, Koshiba-Takeuchi K, Davidson L et al. Tbx5-dependent rheostatic control of cardiac gene expression and morphogenesis. Dev Biol 2006;297:566-586. (Pubitemid 44354936)
54. Niederreither K, Vermot J, Messaddeq N, Schuhbaur B, Chambon P, Dolle P. Embryonic retinoic acid synthesis is essential for heart morphogenesis in the mouse. Development 2001;128:1019-1031. (Pubitemid 32401419)
55. Koshiba-Takeuchi K, Mori AD, Kaynak BL, Cebra-Thomas J, Sukonnik T, Georges RO et al. Reptilian heart development and the molecular basis of cardiac chamber evolution. Nature 2009;461:95-98.
56. Shimizu W. The Brugada syndrome\an update. Intern Med 2005;44:1224-1231.
57. Kies P, Bootsma M, Bax J, Schalij MJ, van der Wall EE. Arrhythmogenic right ventricular dysplasia/cardiomyopathy: screening, diagnosis, and treatment. Heart Rhythm 2006;3:225-234. (Pubitemid 43149999)
58. Gage PJ, Suh H, Camper SA. The bicoid-related Pitx gene family in development. Mamm Genome 1999;10:197-200. (Pubitemid 29390548)
59. Semina EV, Reiter R, Leysens NJ, Alward WL, Small KW, Datson NA et al. Cloning and characterization of a novel bicoid-related homeobox transcription factor gene, RIEG, involved in Rieger syndrome. Nat Genet 1996;14:392-399. (Pubitemid 26414582)
60. Wang J, Klysik E, Sood S, Johnson RL, Wehrens XH, Martin JF. Pitx2 prevents susceptibility to atrial arrhythmias by inhibiting left-sided pacemaker specification. Proc Natl Acad Sci USA 2010;107:9753-9758.
61. Kirchhof P, Kahr PC, Kaese S, Piccini I, Vokshi I, Scheld HH et al. PITX2c is expressed in the adult left atrium, and reducing Pitx2c expression promotes atrial fibrillation induci-bility and complex changes in gene expression. Circ Cardiovasc Genet 2011;4:123-133.
62. Chen YH, Xu SJ, Bendahhou S, Wang XL, Wang Y, Xu WY et al. KCNQ1 gain-of-function mutation in familial atrial fibrillation. Science 2003;299:251-254. (Pubitemid 36125211)
63. Gomez-Skarmeta JL, Modolell J. Iroquois genes: genomic organization and function in vertebrate neural development. Curr Opin Genet Dev 2002;12:403-408. (Pubitemid 34722918)
64. Burglin TR. Analysis of TALE superclass homeobox genes (MEIS, PBC, KNOX, Iro-quois, TGIF) reveals a novel domain conserved between plants and animals. Nucleic Acids Res 1997;25:4173-4180. (Pubitemid 27485191)
65. Bruneau BG, Bao ZZ, Tanaka M, Schott JJ, Izumo S, Cepko CL et al. Cardiac expression of the ventricle-specific homeobox gene Irx4 is modulated by Nkx2-5 and dHand. Dev Biol 2000;217:266-277. (Pubitemid 30060875)
66. Christoffels VM, Keijser AG, Houweling AC, Clout DE, Moorman AF. Patterning the embryonic heart: identification of five mouse Iroquois homeobox genes in the developing heart. Dev Biol 2000;224:263-274. (Pubitemid 30662107)
67. Cheng CW, Chow RL, Lebel M, Sakuma R, Cheung HO, Thanabalasingham V et al. The Iroquois homeobox gene, Irx5, is required for retinal cone bipolar cell development. Dev Biol 2005;287:48-60. (Pubitemid 41587477)
68. Frank-Hansen R, Larsen LA, Andersen P, Jespersgaard C, Christiansen M. Mutations in the genes KCND2 and KCND3 encoding the ion channels Kv4.2 and Kv4.3, conducting the cardiac fast transient outward current (ITO,f), are not a frequent cause of long QT syndrome. Clin Chim Acta 2005;351:95-100. (Pubitemid 39563561)
69. Furushima H, Chinushi M, Okamura K, Iijima K, Komura S, Tanabe Y et al. Comparison of conduction delay in the right ventricular outflow tract between Brugada syndrome and right ventricular cardiomyopathy: investigation of signal average ECG in the precordial leads. Europace 2007;9:951-956. (Pubitemid 351773304)
70. Morita H, Fukushima-Kusano K, Nagase S, Takenaka-Morita S, Nishii N, Kakishita M et al. Site-specific arrhythmogenesis in patients with Brugada syndrome. J Cardiovasc Electrophysiol 2003;14:373-379. (Pubitemid 36529022)
71. de Jong F, OpthofT, Wilde AA, Janse MJ, Charles R,Lamers WHet al. Persisting zones of slow impulse conduction in developing chicken hearts. Circ Res 1992;71:240-250.
72. Black BL. Transcriptional pathways in second heart field development. Semin Cell Dev Biol 2007;18:67-76. (Pubitemid 46343797)
73. Christoffels VM, Hoogaars WM, Tessari A, Clout DE, Moorman AF, Campione M. T-box transcription factor Tbx2 represses differentiation and formation of the cardiac chambers. Dev Dyn 2004;229:763-770. (Pubitemid 38429105)
74. Harrelson Z, Kelly RG, Goldin SN, Gibson-Brown JJ, Bollag RJ, Silver LM et al. Tbx2 is essential for patterning the atrioventricular canal and for morphogenesis of the outflow tract during heart development. Development 2004;131:5041-5052. (Pubitemid 39485361)
75. Aanhaanen WT, Brons JF, Dominguez JN, Rana MS, Norden J, Airik R et al. The Tbx2+ primary myocardium of the atrioventricular canal forms the atrioventricular node and the base of the left ventricle. Circ Res 2009;104:1267-1274.
76. Ou B, Nakagawa M, Kajimoto M, Nobe S, Ooie T, Ichinose M et al. Heterogeneous expression of connexin 43 in the myocardium of rabbit right ventricular outflow tract. Life Sci 2005;77:52-59. (Pubitemid 40546376)
77. Deal BJ, Keane JF, Gillette PC, Garson A Jr. Wolff-Parkinson-White syndrome and supraventricular tachycardia during infancy: management and follow-up. J Am Coll Cardiol 1985;5:130-135. (Pubitemid 15194692)
78. Delhaas T, Sarvaas GJ, Rijlaarsdam ME, Strengers JL, Eveleigh RM, Poulino SE et al. A multicenter, long-term study on arrhythmias in children with Ebstein anomaly. Pediatr Cardiol 2010;31:229-233.
79. Fananapazir L, Tracy CM, Leon MB, Winkler JB, Cannon RO 3rd, Bonow RO et al. Electrophysiologic abnormalities in patients with hypertrophic cardiomyopathy. A consecutive analysis in 155 patients. Circulation 1989;80:1259-1268. (Pubitemid 19282514)
80. Pignatelli RH, McMahon CJ, Dreyer WJ, Denfield SW, Price J, Belmont JW et al. Clinical characterization of left ventricular noncompaction in children: a relatively common form of cardiomyopathy. Circulation 2003;108:2672-2678. (Pubitemid 37466810)
81. Gollob MH, Green MS, Tang AS, Gollob T, Karibe A, Ali Hassan AS et al. Identification of a gene responsible for familial Wolff-Parkinson-White syndrome. N Engl J Med 2001;344:1823-1831. (Pubitemid 32538695)
82. Arad M, Maron BJ, Gorham JM, Johnson WH Jr, Saul JP, Perez-Atayde AR et al. Gly-cogen storage diseases presenting as hypertrophic cardiomyopathy. N Engl J Med 2005;352:362-372.
83. AradM,Moskowitz IP, Patel VV, AhmadF,Perez-Atayde AR, Sawyer DB et al. Transgenic mice overexpressing mutant PRKAG2 define the cause of Wolff-Parkinson-White syndrome in glycogen storage cardiomyopathy. Circulation 2003;107:2850-2856. (Pubitemid 36705997)
84. Sidhu JS, Rajawat YS, Rami TG, Gollob MH, Wang Z, Yuan R et al. Transgenic mouse model of ventricular preexcitation and atrioventricular reentrant tachycardia induced by an AMP-activated protein kinase loss-of-function mutation responsible for Wolff-Parkinson-White syndrome. Circulation 2005;111:21-29. (Pubitemid 40070839)
85. Ko JK, Deal BJ, Strasburger JF, Benson DW Jr. Supraventricular tachycardia mechanisms and their age distribution in pediatric patients. Am J Cardiol 1992;69:1028-1032. (Pubitemid 23058998)
86. Naheed ZJ, Strasburger JF, Deal BJ, Benson DW Jr, Gidding SS. Fetal tachycardia: mechanisms and predictors of hydrops fetalis. J Am Coll Cardiol 1996;27:1736-1740. (Pubitemid 26198028)
87. Kolditz DP, Wijffels MC, Blom NA, van der Laarse A, Markwald RR, Schalij MJ et al. Persistence of functional atrioventricular accessory pathways in postseptated embryonic avian hearts: implications for morphogenesis and functional maturation of the cardiac conduction system. Circulation 2007;115:17-26. (Pubitemid 46058607)
88. Hahurij ND, Gittenberger-De Groot AC, Kolditz DP, Bokenkamp R, Schalij MJ, Poelmann RE et al. Accessory atrioventricular myocardial connections in the developing human heart: relevance for perinatal supraventricular tachycardias. Circulation 2008;117:2850-2858. (Pubitemid 351787077)
89. Tallini YN, Ohkura M, Choi BR, Ji G, Imoto K, Doran R et al. Imaging cellular signals in the heart in vivo: cardiac expression of the high-signal Ca2+ indicator GCaMP2. Proc Natl Acad Sci USA 2006;103:4753-4758.
90. McGuire MA, de Bakker JM, Vermeulen JT, Moorman AF, Loh P, Thibault B et al. Atrioventricular junctional tissue. Discrepancy between histological and electro-physiological characteristics. Circulation 1996;94:571-577. (Pubitemid 26266147)
91. Ma L, Lu MF, Schwartz RJ, Martin JF. Bmp2 is essential for cardiac cushion epithelial-mesenchymal transition and myocardial patterning. Development 2005;132:5601-5611. (Pubitemid 43125885)
92. Le Gloan L, Pichon O, Isidor B, Boceno M, Rival JM, David A et al. A 8.26Mb deletion in 6q16 and a 4.95Mb deletion in 20p12 including JAG1 and BMP2 in a patient with Alagille syndrome and Wolff-Parkinson-White syndrome. Eur J Med Genet 2008;51:651-657.
93. Lalani SR, Thakuria JV, Cox GF, Wang X, Bi W, Bray MS et al. 20p12.3 microdeletion predisposes to Wolff-Parkinson-White syndrome with variable neurocognitive deficits. J Med Genet 2009;46:168-175.
94. Gaussin V, Morley GE, Cox L, Zwijsen A, Vance KM, Emile L et al. Alk3/Bmpr1a receptor is required for development of the atrioventricular canal into valves and annulus fibrosus. Circ Res 2005;97:219-226. (Pubitemid 41105447)
95. Rentschler S, Harris BS, Kuznekoff L, Jain R, Manderfield L, Lu MM et al. Notch signaling regulates murine atrioventricular conduction and the formation of accessory pathways. J Clin Invest 2011;121:525-533.
96. Rottbauer W, Baker K, Wo ZG, Mohideen MA, Cantiello HF, Fishman MC. Growth and function of the embryonic heart depend upon the cardiac-specific L-type calcium channel alpha1 subunit. Dev Cell 2001;1:265-275. (Pubitemid 33653061)
97. Papadatos GA, Wallerstein PM, Head CE, Ratcliff R, Brady PA, Benndorf K et al. Slowed conduction and ventricular tachycardia after targeted disruption of the cardiac sodium channel gene Scn5a. Proc Natl Acad Sci USA 2002;99:6210-6215. (Pubitemid 34493291)
98. Chopra SS, Stroud DM, Watanabe H, Bennett JS, Burns CG, Wells KS et al. Voltage-gated sodium channels are required for heart development in zebrafish. Circ Res 2010;106:1342-1350.
99. Stieber J, Herrmann S, Feil S, Loster J, Feil R, Biel M et al. The hyperpolarization-activated channel HCN4 is required for the generation of pacemaker action potentials in the embryonic heart. Proc Natl Acad Sci USA 2003;100: 15235-15240. (Pubitemid 37518045)
100. Nerbonne J. Molecular analysis of voltage-gated K+ channel diversity and functioning in the mammalian heart. In: Terjung R, ed. Comprehensive Physiology. Wiley; 2010.